The Newsroom
AdventHealth Among First in U.S. to Offer IDP023-2-101 Clinical Trial for Patients with Progressive Multiple Sclerosis
The AdventHealth Neuroscience Institute is the first in Florida and one of the first in the country to begin recruiting patients with primary progressive or non-active secondary progressive multiple...
AdventHealth Research Contributed to New Method for Tracking Diet and Its Impacts on Human Health
Mayor Demings, AdventHealth on bridging health care gaps
Recent Stories at AdventHealthMD
-
-
Chief Clinical Officer Appointed to Serve the AdventHealth East Florida Division
-
AdventHealth Involved in Research to Evaluate First Potential Disease-Modifying Treatment for Epileptic Patients with Dravet Syndrome
-
AdventHealth Neuroscience Institute Secures New Gamma Knife Radiosurgery Platform to Advance Patient Care
-
AdventHealth for Children Collaborating with n-Lorem Foundation to Provide Personalized Treatments to Patients with Nano-rare Genetic Diseases
-
Innovative Spring Sees Three Groundbreaking Cardiovascular Procedures Performed by AdventHealth Physicians
-
Groundbreaking Ozempic study – Conducted in Part at AdventHealth – Could Increase Access for People with Chronic Kidney Disease
-
Pro Volleyball in Central Florida and Breaking Barriers for Female Athletes
-
AdventHealth Orlando is the First in Central Florida to Randomize a Patient in the Global ALLAY-HF Study for Alleviating Heart Failure Symptoms